CME Webcast Teaches on Multimodal Analgesia: Concepts and Strategies to Reduce Opioid Use

OSUWexnerbloglogo2014 CME Webcast Teaches on Multimodal Analgesia: Concepts and Strategies to Reduce Opioid Use. With the invention of the hypodermic syringe and hollow needle in 1850, morphine began to be used for surgical procedures and post-operative pain. However, many people became addicted to morphine so chemists set out to develop safer, more effective, and less addictive opioids. Thus heroin was created by the Bayer pharmaceutical company in 1898. That was followed by the synthesis of meperidine in 1939, methadone in 1946, and fentanyl in 1960. But all of these proved to be just as addictive as morphine. And this has left physicians in general and surgeons in particular with the dilemma of how do you relieve pain and suffering without causing the harm of addiction? Fortunately, we now have some guidance. Joining the webcast to tell us about strategies to treat pain while reducing opioid doses is OSU Professor of Plastic Surgery and the Past President of the American Society of Plastic Surgeons, Dr. Jeffrey Janis.

View a video introduction of this webcast

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to: UNDERSTAND the current epidemiology and causes of the current opioid crisis in the United States; Understand the current opioid prescribing practices for perioperative pain; and DEVELOP intra-operative and post-operative pain management strategies to reduce opioid use.

You’ll also learn about the following:

  • Whether opioids used for pain management result in opioid addiction?
  • Opioid alternatives for pain management

You can find this and many other MedNet21 programs on the OSU – CCME website.

Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at derrick.freeman@osumc.edu.

Get the Latest Information on Medical Marijuana with On-line Education

OSUWexnerbloglogo2014 Get the Latest Information on Medical Marijuana with On-line Education. One of the most recent states to legalize medical marijuana is Ohio where a new medical marijuana law went into effect earlier this month. But it is not without controversy, however. And it is really difficult to find objective, scientific data on the medicinal effects of marijuana. On this CME webcast, we’ve brought in two of the Ohio State University’s top experts on marijuana to give us an unbiased review of medical marijuana and we’re going to frame the discussion in the context of Ohio’s new medical marijuana law. To review the pharmacology of marijuana, palliative medicine clinical pharmacist, and to tell us more about the medical uses of marijuana is Professor of Internal Medicine and the long-standing chairman of the OSU Pharmacy and Therapeutics committee, Dr. Harrison Weed.

View a video introduction of this webcast

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to: UNDERSTAND the currently accepted appropriate uses of medical marijuana; and UNDERSTAND the potential
adverse consequences of medical marijuana.

You’ll also learn about the following:

  • Current pharmacologic uses of cannabinoids
  • Medicinal properties of marijuana
  • Hemp versus marijuana
  • The Ohio Automated Rx Reporting System (OARRS)
  • Hospital approaches to inpatient use of medical marijuana
  • Purity testing and labeling

You can find this and many other MedNet21 programs on the OSU – CCME website.

Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at derrick.freeman@osumc.edu.

Learn About Treatment of Opioid Dependency on CME Webcast

OSUWexnerbloglogo2014 Learn About Treatment of Opioid Dependency on CME Webcast. In the 55 years since Dr. Dole began his ground breaking research in the treatment of opioid addiction, we have come a long way toward better understanding the effects of opioids and toward developing effective treatment for opioid addiction. However all of these advances have been eclipsed by increased opioid use in the United States fueled by the unbridled prescription of opioid pain relievers in the 1990’s and 2000’s, by price reduction in heroin on the streets, and by recent availability of newer high potency opioids such as fentanyl. But there is hope and on this CME webcast, we’re going to hear about some of the effective solutions to opioid addiction. Here with me in the studio is addiction specialist and Assistant Professor of Psychiatry, Dr. Casia Horseman.

View a video introduction of this webcast

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to: REVIEW the assessment of opioid use disorder; and DESCRIBE pharmacological and psychosocial treatments for opioid use disorder.

You’ll also learn about the following:

  • Demographics of opioid addiction
  • Why opioid use is such a growing problem
  • Why patients relapse
  • Treatment selection strategies
  • The role of the primary care physician in the treatment of opioid use disorder
  • Insurance coverage for treatment
  • Time-limited opioid prescriptions to relieve withdrawal symptoms
  • Inpatient management of the patient already on medication treatment for opioid addiction

You can find this and many other MedNet21 programs on the OSU – CCME website.

Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at derrick.freeman@osumc.edu.

CME Webcast Discusses Use and Complications of NSAIDs

OSUWexnerbloglogo2014 CME Webcast Discusses Use and Complications of NSAIDs. We have lots of choices of NSAIDs and these drugs can be highly effective in relieving pain and suffering. But they can also have serious side effects. On this CME webcast, we’re going to explore the use and the complications of non-steroidal anti-inflammatory drugs. Joining our moderator in the studio is rheumatologist and Assistant Professor of Internal Medicine, Dr. Sheryl Mascarenhas.

View a video introduction of this webcast

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to: GAIN an enhanced understanding of NSAID use with regard to various clinical scenarios and patient comorbidities; and IMPROVE familiarity with complications of NSAIDs and better understand ways to limit these complications.

You’ll also learn about the following:

  • Whether all NSAIDs equally effective
  • Whether all NSAIDs have the same side effects
  • Intravenous NSAIDs
  • Rofecoxib (Vioxx)

You can find this and many other MedNet21 programs on the OSU – CCME website.

Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at derrick.freeman@osumc.edu.

On-line Enduring Material Teaches on Adrenal Nodules

OSUWexnerbloglogo2014 On-line Enduring Material Teaches on Adrenal Nodules. Pheochromocytomas are fairly rare with about 1,000 cases in the U.S. every year but overall, adrenal tumors are common, and you can find one in about every 20 patients who undergo abdominal CT scans. Most of these adrenal tumors are benign and require no treatment but knowing which ones are consequential and which ones are inconsequential can be a challenge. On this CME webcast, to show you how to manage the incidentally identified adrenal tumor is surgical oncologist and Assistant Professor of Surgery at the Ohio State University, we have Dr. Drew Shirley.

View a video introduction of this webcast

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to: UNDERSTAND the imaging characteristics used to determine treatment strategies for adrenal nodules; and USE biochemical tests to aid in the diagnosis of functional adrenal nodules.

You’ll also learn about the following:

  • Causes of adrenal nodules
  • Which adrenal nodule need to be biopsied
  • Familial syndromes involving adrenal tumors
  • Incidental adrenal nodules found when staging lung cancer
  • Performing adrenal nodule needle biopsy and FNA
  • What to expect during and after adrenal surgery
  • Approach to adrenal hemorrhage
  • Radiographic imaging follow-up of adrenal nodules
  • Laboratory follow-up of adrenal nodules in patients with hypertension

You can find this and many other MedNet21 programs on the OSU – CCME website.

Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at derrick.freeman@osumc.edu.